vs

Side-by-side financial comparison of MEDIFAST INC (MED) and Vitesse Energy, Inc. (VTS). Click either name above to swap in a different company.

MEDIFAST INC is the larger business by last-quarter revenue ($75.1M vs $58.6M, roughly 1.3× Vitesse Energy, Inc.). On growth, Vitesse Energy, Inc. posted the faster year-over-year revenue change (4.8% vs -36.9%). Over the past eight quarters, Vitesse Energy, Inc.'s revenue compounded faster (-2.1% CAGR vs -34.4%).

Medifast, Inc. is an American nutrition and weight loss company based in Baltimore, Maryland. Medifast produces, distributes, and sells weight loss and health-related products through websites, multi-level marketing, telemarketing, and franchised weight loss clinics.

Vitesse Energy, Inc. is a U.S.-headquartered independent energy company focused on exploration, development, and production of oil and natural gas assets. It operates primarily in high-potential onshore basins including North Dakota's Williston Basin, serving domestic and global upstream energy market demand.

MED vs VTS — Head-to-Head

Bigger by revenue
MED
MED
1.3× larger
MED
$75.1M
$58.6M
VTS
Growing faster (revenue YoY)
VTS
VTS
+41.7% gap
VTS
4.8%
-36.9%
MED
Faster 2-yr revenue CAGR
VTS
VTS
Annualised
VTS
-2.1%
-34.4%
MED

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
MED
MED
VTS
VTS
Revenue
$75.1M
$58.6M
Net Profit
$-739.0K
Gross Margin
69.4%
Operating Margin
-10.4%
-12.0%
Net Margin
-1.3%
Revenue YoY
-36.9%
4.8%
Net Profit YoY
85.6%
EPS (diluted)
$-1.64
$-0.01

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
MED
MED
VTS
VTS
Q4 25
$75.1M
$58.6M
Q3 25
$89.4M
$67.4M
Q2 25
$105.6M
$81.8M
Q1 25
$115.7M
$66.2M
Q4 24
$119.0M
$55.9M
Q3 24
$140.2M
$58.3M
Q2 24
$168.6M
$66.6M
Q1 24
$174.7M
$61.2M
Net Profit
MED
MED
VTS
VTS
Q4 25
$-739.0K
Q3 25
$-2.3M
$-1.3M
Q2 25
$2.5M
$24.7M
Q1 25
$-772.0K
$2.7M
Q4 24
$-5.1M
Q3 24
$1.1M
$17.4M
Q2 24
$-8.2M
$10.9M
Q1 24
$8.3M
$-2.2M
Gross Margin
MED
MED
VTS
VTS
Q4 25
69.4%
Q3 25
69.5%
Q2 25
72.6%
Q1 25
72.8%
Q4 24
74.1%
Q3 24
75.4%
Q2 24
73.2%
Q1 24
72.8%
Operating Margin
MED
MED
VTS
VTS
Q4 25
-10.4%
-12.0%
Q3 25
-4.6%
0.2%
Q2 25
-1.0%
22.8%
Q1 25
-1.1%
8.1%
Q4 24
0.6%
3.7%
Q3 24
1.5%
15.4%
Q2 24
-4.7%
25.2%
Q1 24
4.5%
21.4%
Net Margin
MED
MED
VTS
VTS
Q4 25
-1.3%
Q3 25
-2.5%
-1.9%
Q2 25
2.3%
30.2%
Q1 25
-0.7%
4.0%
Q4 24
-9.2%
Q3 24
0.8%
29.9%
Q2 24
-4.8%
16.4%
Q1 24
4.8%
-3.6%
EPS (diluted)
MED
MED
VTS
VTS
Q4 25
$-1.64
$-0.01
Q3 25
$-0.21
$-0.03
Q2 25
$0.22
$0.60
Q1 25
$-0.07
$0.08
Q4 24
$0.08
$-0.15
Q3 24
$0.10
$0.53
Q2 24
$-0.75
$0.33
Q1 24
$0.76
$-0.07

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
MED
MED
VTS
VTS
Cash + ST InvestmentsLiquidity on hand
$167.3M
Total DebtLower is stronger
Stockholders' EquityBook value
$198.9M
$629.3M
Total Assets
$248.0M
$893.4M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
MED
MED
VTS
VTS
Q4 25
$167.3M
Q3 25
$173.5M
Q2 25
$162.7M
Q1 25
$164.6M
$4.5M
Q4 24
$162.3M
$3.0M
Q3 24
$170.0M
Q2 24
$163.5M
Q1 24
$156.4M
Stockholders' Equity
MED
MED
VTS
VTS
Q4 25
$198.9M
$629.3M
Q3 25
$214.7M
$650.3M
Q2 25
$216.0M
$671.9M
Q1 25
$211.0M
$667.7M
Q4 24
$210.1M
$500.3M
Q3 24
$207.3M
$520.4M
Q2 24
$205.3M
$518.5M
Q1 24
$211.0M
$522.7M
Total Assets
MED
MED
VTS
VTS
Q4 25
$248.0M
$893.4M
Q3 25
$268.2M
$932.9M
Q2 25
$269.3M
$951.5M
Q1 25
$280.0M
$975.2M
Q4 24
$284.2M
$810.9M
Q3 24
$291.2M
$791.2M
Q2 24
$293.5M
$778.4M
Q1 24
$302.8M
$749.7M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
MED
MED
VTS
VTS
Operating Cash FlowLast quarter
$-5.3M
$37.4M
Free Cash FlowOCF − Capex
$-6.6M
FCF MarginFCF / Revenue
-8.8%
Capex IntensityCapex / Revenue
1.8%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$1.2M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
MED
MED
VTS
VTS
Q4 25
$-5.3M
$37.4M
Q3 25
$12.1M
$49.4M
Q2 25
$-3.4M
$66.0M
Q1 25
$3.4M
$17.5M
Q4 24
$-4.9M
$34.7M
Q3 24
$9.1M
$45.7M
Q2 24
$13.1M
$35.2M
Q1 24
$7.3M
$39.4M
Free Cash Flow
MED
MED
VTS
VTS
Q4 25
$-6.6M
Q3 25
$10.8M
Q2 25
$-4.8M
Q1 25
$1.9M
Q4 24
$-7.2M
Q3 24
$7.7M
Q2 24
$11.1M
Q1 24
$5.4M
FCF Margin
MED
MED
VTS
VTS
Q4 25
-8.8%
Q3 25
12.0%
Q2 25
-4.5%
Q1 25
1.6%
Q4 24
-6.1%
Q3 24
5.5%
Q2 24
6.6%
Q1 24
3.1%
Capex Intensity
MED
MED
VTS
VTS
Q4 25
1.8%
Q3 25
1.5%
Q2 25
1.3%
Q1 25
1.3%
Q4 24
1.9%
Q3 24
1.0%
Q2 24
1.1%
Q1 24
1.1%
Cash Conversion
MED
MED
VTS
VTS
Q4 25
Q3 25
Q2 25
-1.36×
2.68×
Q1 25
6.56×
Q4 24
Q3 24
8.04×
2.62×
Q2 24
3.22×
Q1 24
0.88×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

MED
MED

Segment breakdown not available.

VTS
VTS

Oil Reserves$54.5M93%
Natural Gas Reserves$4.2M7%

Related Comparisons